Trial Site Detail

 

Drug:
XL228
Trial:
Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

UCLA's Jonsson Comprehensive Cancer Center

10945 Le Conte Ave.     
Los Angeles , CA 90095
USA

 

Principal Investigator:
Carolyn Britten, MD
Contact:
Lisa Yonemoto 310-825-4477
Activation Status of this Site:
Closed
Notes about this Site:
UCLA's Jonsson Comprehensive Cancer Center Website:
http://www.cancer.ucla.edu/Index.aspx?page=51

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.